People | June 29, 2022
DTx Pharma appoints Peter Condon as Chief Business Officer
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
The Congress was held on June, 20-21, 2022 in Berlin, Germany
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019
Bringing next-gen cannabinoid therapeutics to cancer patients
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Subscribe To Our Newsletter & Stay Updated
